
U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Friday.
Shares of Revolution Medicines Inc (NASDAQ:RVMD) rose sharply during Friday's session after the company announced that the FDA granted the company a non-transferrable voucher for daraxonrasib, the company’s RAS(ON) multi-selective inhibitor, under the Commissioner’s National Priority Voucher pilot program.